Adipokines and Systemic Inflammation in Weight-losing Lung Cancer Patients

Overview

Journal Lung

Specialty Pulmonary Medicine

Date 2012 Jan 17

PMID 22246553

Citations 24

Authors

Sule T Gulen

Fisun Karadag

Aslihan B Karul

Naciye Kilicarslan

Emel Ceylan

Nilgun K Kuman

Orhan Cildag

Affiliations

Soon will be listed here.

Abstract

Background: Cancer cachexia is a devastating condition leading to loss of function and independence, decreased performance status, decreased quality of life, and poor prognosis. Adipokines play a role in a wide variety of physiological or pathological processes, including immunity and inflammation, in addition to having significant effects on metabolism and lipogenesis. The objective of the present study was to investigate the relationship of adipokines and systemic inflammation in weight-losing advanced-stage non-small-cell lung cancer (NSCLC) patients.

Methods: Sixty-three male NSCLC patients (stages III and IV) and 25 age- and sex-matched controls were included. NSCLC patients were further divided into subgroups as those with a>5% weight loss in last 6 months and those who did not. Serum leptin, adiponectin, and TNF-α concentrations were measured by ELISA using commercially available kits.

Results: The positive acute-phase reactants (APR) CRP, leukocyte, ferritin, thrombocyte, and fibrinogen were higher in the NSCLC group. Serum albumin level (which is a negative APR) was lower in the cancer group, whereas there was no difference in transferrin level between the groups. TNF-α and leptin concentrations were similar in the cancer group and the control group, whereas adiponectin was lower in the cancer group. There was a difference in thrombocyte and transferrin levels between patients with and without weight loss, whereas CRP, TNF-α, and adiponectin levels were similar. Leptin was lower in weight-losing cancer patients. However, there was no correlation between adipokines and markers of systemic inflammation.

Conclusion: These results revealed a lack of association between adipokine levels and systemic inflammation with cancer cachexia.

Citing Articles

Putative Molecular Mechanisms Underpinning the Inverse Roles of Mitochondrial Respiration and Heme Function in Lung Cancer and Alzheimer's Disease.

Afsar A, Zhang L Biology (Basel). 2024; 13(3).

PMID: 38534454 PMC: 10967737. DOI: 10.3390/biology13030185.

Obesity and lung cancer - is programmed death ligand-1 (PD-1L) expression a connection?.

Galazka J, Czeczelewski M, Kucharczyk T, Szklener K, Mandziuk S Arch Med Sci. 2024; 20(1):313-316.

PMID: 38414472 PMC: 10895970. DOI: 10.5114/aoms/175470.

Cancer Cachexia: New Insights and Future Directions.

Mariean C, Tiuca O, Mariean A, Cotoi O Cancers (Basel). 2023; 15(23).

PMID: 38067294 PMC: 10705516. DOI: 10.3390/cancers15235590.

Cancer- and cardiac-induced cachexia: same fate through different inflammatory mediators?.

Nogueira-Ferreira R, Sousa-Nunes F, Leite-Moreira A, Moreira-Costa L, Vitorino R, Santos L Inflamm Res. 2022; 71(7-8):771-783.

PMID: 35680678 DOI: 10.1007/s00011-022-01586-y.

The Prognostic Role and Nomogram Establishment of a Novel Prognostic Score Combining with Fibrinogen and Albumin Levels in Patients with WHO Grade II/III Gliomas.

Jia T, Zhang R, Kong F, Zhang Q, Xi Z Int J Gen Med. 2021; 14:2137-2145.

PMID: 34093034 PMC: 8169085. DOI: 10.2147/IJGM.S303733.

References

Werynska B, Kosacka M, Golecki M, Jankowska R . [Leptin serum levels in cachectic and non-cachectic lung cancer patients]. Pneumonol Alergol Pol. 2009; 77(6):500-6. View

Bruun J, Lihn A, Verdich C, Pedersen S, Toubro S, Astrup A . Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab. 2003; 285(3):E527-33. DOI: 10.1152/ajpendo.00110.2003. View

Otero M, Lago R, Lago F, Casanueva F, Dieguez C, Gomez-Reino J . Leptin, from fat to inflammation: old questions and new insights. FEBS Lett. 2005; 579(2):295-301. DOI: 10.1016/j.febslet.2004.11.024. View

Wang B, Jenkins J, Trayhurn P . Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha. Am J Physiol Endocrinol Metab. 2004; 288(4):E731-40. DOI: 10.1152/ajpendo.00475.2004. View

Popa C, Netea M, Radstake T, van Riel P, Barrera P, van der Meer J . Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis. 2005; 64(8):1195-8. PMC: 1755600. DOI: 10.1136/ard.2004.032243. View

Martin F, Santolaria F, Batista N, Milena A, Gonzalez-Reimers E, Brito M . Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine. 1999; 11(1):80-6. DOI: 10.1006/cyto.1998.0398. View

Inui A . Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin. 2002; 52(2):72-91. DOI: 10.3322/canjclin.52.2.72. View

Carlson G, Saeed M, Little R, Irving M . Serum leptin concentrations and their relation to metabolic abnormalities in human sepsis. Am J Physiol. 1999; 276(4):E658-62. DOI: 10.1152/ajpendo.1999.276.4.E658. View

Trayhurn P, Wood I . Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004; 92(3):347-55. DOI: 10.1079/bjn20041213. View

10.

Malli F, Papaioannou A, Gourgoulianis K, Daniil Z . The role of leptin in the respiratory system: an overview. Respir Res. 2010; 11:152. PMC: 2988727. DOI: 10.1186/1465-9921-11-152. View

11.

McKeown D, Brown D, Kelly A, Wallace A, McMillan D . The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer. Br J Cancer. 2004; 91(12):1993-5. PMC: 2410147. DOI: 10.1038/sj.bjc.6602248. View

12.

Detterbeck F, Boffa D, Tanoue L . The new lung cancer staging system. Chest. 2009; 136(1):260-271. DOI: 10.1378/chest.08-0978. View

13.

Simons J, Schols A, Buurman W, Wouters E . Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond). 1999; 97(2):215-23. View

14.

Simons J, Schols A, Campfield L, Wouters E, Saris W . Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin Sci (Lond). 1997; 93(3):273-7. DOI: 10.1042/cs0930273. View

15.

Aleman M, Santolaria F, Batista N, De La Vega M, Gonzalez-Reimers E, Milena A . Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition?. Cytokine. 2002; 19(1):21-6. DOI: 10.1006/cyto.2002.1051. View

16.

Acharyya S, Ladner K, Nelsen L, Damrauer J, Reiser P, Swoap S . Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest. 2004; 114(3):370-8. PMC: 484974. DOI: 10.1172/JCI20174. View

17.

Lago F, Dieguez C, Gomez-Reino J, Gualillo O . Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol. 2007; 3(12):716-24. DOI: 10.1038/ncprheum0674. View

18.

Deans C, Wigmore S . Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care. 2005; 8(3):265-9. DOI: 10.1097/01.mco.0000165004.93707.88. View

19.

Scott H, McMillan D, Brown D, Forrest L, McArdle C, Milroy R . A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer. Lung Cancer. 2003; 40(3):295-9. DOI: 10.1016/s0169-5002(03)00077-1. View

20.

Jamieson N, Brown D, Michael Wallace A, McMillan D . Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer. Cytokine. 2004; 27(2-3):90-2. DOI: 10.1016/j.cyto.2004.03.017. View